SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED
Summary
SHPL is a 50:50 joint venture established in 2001 between HUTCHMED and Shanghai Pharma. It primarily manufactures, sells and distributes own-brand cardiovascular diseases medicines in China.
Deals Overview
Total Dealss1
Valued Deals1
Total Value£ 485 M
Avg. Deal Size£ 485 M
All rights reserved. Copyright © 2025 Datasite